Ledger.Open graph →
SEC Form D · filed April 11, 2018

Dianomi Therapeutics, Inc

Offering
$2.0M
Sold
$185K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PARKER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Barry Kurokawa · Parker, COExec · DirectorKyle Volluz · DALLAS, TXExec · DirectorKurtis Knapp · Parker, COExec · DirectorWilliam Murphy · Parker, COExec · DirectorCarter Cliff · Parker, COExec · DirectorVictor Petroff · Tukwila, WAExec · DirectorKurtis Knapp · Parker, COExec · DirectorWilliam Murphy · Parker, COExec · DirectorCarter Cliff · Parker, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗